Trial to Evaluate Efficacy and Safety of Nitazoxanide in the Treatment of Mild or Moderate COVID-19

NCT04486313 PHASE3 COMPLETED Results posted

Trial to Evaluate Efficacy and Safety of Nitazoxanide in the Treatment of Mild or Moderate COVID-19

Details

Lead sponsor	Romark Laboratories L.C.
Phase	PHASE3
Status	COMPLETED
Enrolment	935
Start date	Thu Aug 13 2020 00:00:00 GMT+0000 (Coordinated Universal Time)
Completion	Mon Feb 08 2021 00:00:00 GMT+0000 (Coordinated Universal Time)

Conditions

• COVID-19

Interventions

• Nitazoxanide
• Placebo
• Vitamin Super B-Complex

Countries

United States